New York is currently home to 4441 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New York, Rochester, Bronx and Buffalo. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
Recruiting
Prospective, multi-center, international, unblinded, single-arm trial of subjects undergoing FemBloc followed by ultrasound confirmation test.
Gender:
FEMALE
Ages:
Between 21 years and 50 years
Trial Updated:
01/24/2025
Locations: Maimonides Medical Center, Brooklyn, New York
Conditions: Contraception
Forward Looking InfraRed Imaging and Severity Score in Complex Regional Pain Syndrome
Recruiting
The goal of this interventional study is to explore the use of InfraRed (FLIR) imaging in determining pain intensity and severity in newly diagnosed complex regional pain syndrome patients. The main questions it aims to answer are: Question 1: Can Infrared (FLIR) imaging be used to determine the severity of CRPS in newly diagnosed patients? Question 2: Is there any correlation with the quantification of 'the Ī” thermal index value' measured by FLIR imaging with pain intensity (NRS) in newly diag... Read More
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
01/24/2025
Locations: Hospital for Special Surgery, New York, New York
Conditions: CRPS (Complex Regional Pain Syndromes)
An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias
Recruiting
The goal of this clinical study is to evaluate povetacicept in adults with autoimmune cytopenias of immune thrombocytopenia, autoimmune hemolytic anemia, and cold agglutinin disease to determine if povetacicept is safe and potentially beneficial in treating these diseases. During the study treatment period participants will receive povetacicept approximately every 4 weeks for 6 months, with the possibility of participating in a 6-month study treatment extension period.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/24/2025
Locations: Investigational Site (422), Bronx, New York
Conditions: Immune Thrombocytopenia, Idiopathic Thrombocytopenic Purpura, Warm Autoimmune Hemolytic Anemia, Cold Agglutinin Disease
Real-world Clinical Outcomes of the MITRIS RESILIA Mitral Valve
Recruiting
Collect real-world data on acute and long-term safety and performance of the MITRIS RESILIA Mitral Valve, Model 11400M, in subjects requiring replacement of their native or prosthetic mitral valve with or without concomitant procedures.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/24/2025
Locations: Mount Sinai Hospital, New York, New York
Conditions: Mitral Stenosis, Mitral Valve Insufficiency
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
Recruiting
This study is an efficacy-implementation trial to: 1. evaluate systematically the efficacy of BREATHE in 200 Black adults receiving care at urban federally qualified health centers (FQHCs) for uncontrolled asthma; and 2. identify multi-level barriers and facilitators to the widespread adoption and implementation of BREATHE in FQHCs.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/24/2025
Locations: Sun River Health, Beacon, New York
Conditions: Asthma
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
Recruiting
The goal of this observational study is to determine the clinical validity of a deep neural network algorithm that utilizes protein biomarker detection of Endometriosis - "EndoCheck" - as an "aid in diagnosis" for endometriosis and to show validity as a diagnostic test
Gender:
FEMALE
Ages:
Between 14 years and 50 years
Trial Updated:
01/24/2025
Locations: Nezhat Surgery for Gynecology/Oncology, Valley Stream, New York
Conditions: Endometriosis
EMS Providers' Health Initiative Study
Recruiting
This study aims to explore dietary factors that influence glycemic control in night shift EMS providers and to test the feasibility of a dietary intervention among these providers.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/24/2025
Locations: University at Buffalo, Buffalo, New York
Conditions: Shift-work Disorder
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
Recruiting
This is a live biobank study for breast cancer (BC) patients where samples will be collected at inflection points in the course of the disease.
Gender:
FEMALE
Ages:
Between 18 years and 90 years
Trial Updated:
01/24/2025
Locations: Brooklyn Methodist Hospital - NewYork Presbyterian, New York, New York
Conditions: Breast Cancer
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis
Recruiting
This trial will evaluate efficacy, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks (q4w) or every 12 weeks (q12w) compared to placebo, in combination with SoC, in adult participants with active LN
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
01/24/2025
Locations: James J Peters VA Medical Center, Bronx, New York
Conditions: Lupus Nephritis
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
Recruiting
This study seeks to evaluate the impact of intra-operative topical epidural steroid usage in patients undergoing 1-2 level lumbar laminectomy. The study will examine post-operative opioid usage, length of stay, return to work, and patient reported outcomes following these procedures.
Gender:
ALL
Ages:
Between 18 years and 85 years
Trial Updated:
01/24/2025
Locations: Hospital for Special Surgery, New York, New York
Conditions: Opioid Use, Lumbar Spinal Stenosis, Pain, Postoperative, Pain, Back
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVT
Recruiting
This is a study of a medical procedure that utilizes a commercially available catheter (the BullfrogĀ® Micro-Infusion Device) to locally deliver a commercially available anti-inflammatory drug (dexamethasone sodium phosphate injection) around the deep veins after DVT recanalization, where DVT symptoms were present for up to 14 days prior to recanalization. The goal of the study is to see if local anti-inflammation helps prevent re-thrombosis of the blood vessel and improvement in symptoms for up... Read More
Gender:
ALL
Ages:
Between 18 years and 89 years
Trial Updated:
01/24/2025
Locations: Stony Brook University Hospital, Stony Brook, New York
Conditions: Thrombosis, Deep Vein, Iliofemoral; Thrombosis
Combined Immunotherapies in Metastatic ER+ Breast Cancer
Recruiting
Women with Hormone Receptor (HR)+ Human Epidermal growth factor Receptor (HER)2- metastatic breast cancer are eligible to a randomized trial. Patients receiving standard first line therapy for metastatic HR+ Breast cancer(BC) (letrozole+palbociclib) are randomly assigned to also receive Stereotactic Body Radiation Therapy(SBRT) to each metastatic lesion.
Gender:
FEMALE
Ages:
Between 18 years and 90 years
Trial Updated:
01/24/2025
Locations: Weill Cornell Medicine, New York, New York
Conditions: Breast Cancer